Literature DB >> 26809954

Effects of Acute Stroke Serum on Non-Ischemic Cerebral and Mesenteric Vascular Function.

Isabella Canavero1, Helene A Sherburne1, Sarah M Tremble1, Wayne M Clark2, Marilyn J Cipolla3,4,5.   

Abstract

We investigated the effects of circulating factors in serum obtained from patients in the acute phase of different subtypes of ischemic stroke on non-ischemic cerebral and mesenteric arteries, as a potential mechanism involved in influencing regional perfusion and thus clinical evolution. Posterior cerebral arteries (PCAs) and mesentery arteries (MAs) isolated from Wistar Kyoto rats were perfused with serum from acute stroke patients with large vessel disease without (LVD) or with hypertension (LVD + HTN), cardioembolism with hypertension (CE + HTN), or physiologic saline as controls. Myogenic activity and nitric oxide-dependent vasorelaxation were assessed after 2 h of intraluminal exposure to serum. Vascular function was differentially affected by sera. Exposure to LVD serum increased myogenic tone and produced endothelial dysfunction in both PCAs and MAs. However, CE + HTN serum increased tone and decreased smooth muscle sensitivity to NO in vessels from both vascular beds. LVD + HTN serum was associated with reduced smooth muscle sensitivity to NO in vessels from both vascular beds but increased tone only in PCAs. Inflammation and oxidative stress, determined by measurement of high sensitivity C-reactive protein, uric acid, and free 8-isoprostane, were enhanced in all the serum groups. These results demonstrate vasoactive properties of acute stroke serum related to stroke subtypes that could potentially contribute to the pathogenesis of early hemodynamic-based clinical events.

Entities:  

Keywords:  Acute stroke; Circulating factors; Free 8-isoprostane; Inflammation; Oxidative stress; Stroke subtypes

Mesh:

Substances:

Year:  2016        PMID: 26809954      PMCID: PMC4775304          DOI: 10.1007/s12975-016-0449-7

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  41 in total

Review 1.  Cerebral autoregulation in stroke: a review of transcranial Doppler studies.

Authors:  Marcel J H Aries; Jan W Elting; Jacques De Keyser; Berry P H Kremer; Patrick C A J Vroomen
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Blood pressure and clinical outcomes in the International Stroke Trial.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Stephen J Phillips; Peter A G Sandercock
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Inhibition of protein kinase Cβ reverses increased blood-brain barrier permeability during hyperglycemic stroke and prevents edema formation in vivo.

Authors:  Marilyn J Cipolla; Quillan Huang; Julie G Sweet
Journal:  Stroke       Date:  2011-08-18       Impact factor: 7.914

5.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 6.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

7.  Constrictor and dilator effects of angiotensin II on cerebral arterioles.

Authors:  Jean-Martin Vincent; Yiu Wa Kwan; Siu Lung Chan; Caroline Perrin-Sarrado; Jeffrey Atkinson; Jean-Marc Chillon
Journal:  Stroke       Date:  2005-11-03       Impact factor: 7.914

8.  Resistance artery adaptation to pregnancy counteracts the vasoconstricting influence of plasma from normal pregnant women.

Authors:  Odül A Amburgey; Shane A Reeves; Ira M Bernstein; Marilyn J Cipolla
Journal:  Reprod Sci       Date:  2009-09-18       Impact factor: 3.060

9.  Flow-mediated dilatation and intima-media thickness in patients with lacunar infarctions.

Authors:  J Pretnar-Oblak; M Sabovic; T Pogacnik; M Sebestjen; M Zaletel
Journal:  Acta Neurol Scand       Date:  2006-04       Impact factor: 3.209

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  3 in total

1.  Circulating leucocytes perpetuate stroke-induced aortic dysfunction.

Authors:  Shinichi Asano; Grant C O'Connell; Kent C Lemaster; Evan R DeVallance; Kayla W Branyan; James W Simpkins; Jefferson C Frisbee; Taura L Barr; Paul D Chantler
Journal:  Exp Physiol       Date:  2017-09-02       Impact factor: 2.969

Review 2.  Cerebral venous collaterals: A new fort for fighting ischemic stroke?

Authors:  Lu-Sha Tong; Zhen-Ni Guo; Yi-Bo Ou; Yan-Nan Yu; Xiao-Cheng Zhang; Jiping Tang; John H Zhang; Min Lou
Journal:  Prog Neurobiol       Date:  2017-12-02       Impact factor: 11.685

3.  Plasma low-molecular-weight thiol/disulphide homeostasis as an early indicator of global and focal cerebral ischaemia.

Authors:  Alexander Vladimirovich Ivanov; Valery Vasil'evich Alexandrin; Alexander Alexandrovich Paltsyn; Ksenya Alexandrovna Nikiforova; Edward Danielevich Virus; Boris Petrovich Luzyanin; Marina Yurievna Maksimova; Mikhail Aleksanrovich Piradov; Aslan Amirkhanovich Kubatiev
Journal:  Redox Rep       Date:  2017-04-08       Impact factor: 4.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.